AU2005907190A0 - Use of Naltrexone for Treating Alzheimers Disease - Google Patents

Use of Naltrexone for Treating Alzheimers Disease

Info

Publication number
AU2005907190A0
AU2005907190A0 AU2005907190A AU2005907190A AU2005907190A0 AU 2005907190 A0 AU2005907190 A0 AU 2005907190A0 AU 2005907190 A AU2005907190 A AU 2005907190A AU 2005907190 A AU2005907190 A AU 2005907190A AU 2005907190 A0 AU2005907190 A0 AU 2005907190A0
Authority
AU
Australia
Prior art keywords
naltrexone
alzheimers disease
treating alzheimers
treating
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005907190A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edith Cowan University
Original Assignee
Edith Cowan University
Filing date
Publication date
Application filed by Edith Cowan University filed Critical Edith Cowan University
Publication of AU2005907190A0 publication Critical patent/AU2005907190A0/en
Abandoned legal-status Critical Current

Links

AU2005907190A 2005-12-21 Use of Naltrexone for Treating Alzheimers Disease Abandoned AU2005907190A0 (en)

Publications (1)

Publication Number Publication Date
AU2005907190A0 true AU2005907190A0 (en) 2006-01-12

Family

ID=

Similar Documents

Publication Publication Date Title
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
ZA200805877B (en) Pyridiazinone derivatives for tumour treatment
IL196470A (en) Antagonist antibody for the treatment of cancer
AU2006279280A8 (en) Methods and compositions for treating neurological disease
EP2081892A4 (en) Compounds and methods for treating protein folding disorders
IL188430A0 (en) Treatment of tumors
EP1901733A4 (en) Use of huperzine for disorders
HK1117780A1 (en) Compounds and methods for the treatment of cancer
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
EP1858499A4 (en) Methods for treatment of retinal degenerative disease
GB0517387D0 (en) Combinations for the treatment of cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0400802D0 (en) Compounds for the treatment of disease
IL226363A0 (en) Compounds and methods for the treatment of cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
AU2005907190A0 (en) Use of Naltrexone for Treating Alzheimers Disease
AU2005907140A0 (en) Use of Naltrexone for Treating Alzheimers Disease
AU2006907286A0 (en) Use of Naltrexone for Treating Alzheimers Disease
AU2007907088A0 (en) Use of Naltrexone for Treating Alzheimers Disease
GB0517386D0 (en) Combinations for the treatment of cancer
AU2005902378A0 (en) Preparation for treating psoriasis
GB0516753D0 (en) Molecular methods for the treatment of disease
AU2005904004A0 (en) Compounds for medicinal treatment
GB0415352D0 (en) Compounds for the treatment of disease